Jaejin An to Risk Assessment
This is a "connection" page, showing publications Jaejin An has written about Risk Assessment.
Connection Strength
1.111
-
Cardiovascular and Kidney Events Associated with Visit-to-Visit Blood Pressure Variability among Young Adults with Hypertension. Am J Hypertens. 2026 Aug 01; 39(8):988-996.
Score: 0.180
-
PREVENT Equation Performance in Asian and Native Hawaiian and Other Pacific Islander Groups. JAMA Netw Open. 2026 02 02; 9(2):e2556915.
Score: 0.174
-
Development and Validation of an Incident Hypertension Risk Prediction Model for Young Adults. J Am Heart Assoc. 2025 Jul 15; 14(14):e040769.
Score: 0.167
-
Evaluation and Comparison of the PREVENT and Pooled Cohort Equations for 10-Year Atherosclerotic Cardiovascular Risk Prediction. J Am Heart Assoc. 2025 Feb 18; 14(4):e039454.
Score: 0.162
-
Incidence of Atherosclerotic Cardiovascular Disease in Young Adults at Low Short-Term But High Long-Term?Risk. J Am Coll Cardiol. 2023 Feb 21; 81(7):623-632.
Score: 0.142
-
Recurrent Atherosclerotic Cardiovascular Event Rates Differ Among Patients Meeting the Very High Risk Definition According to Age, Sex, Race/Ethnicity, and Socioeconomic Status. J Am Heart Assoc. 2020 12; 9(23):e017310.
Score: 0.121
-
Stroke and Bleeding Risk Associated With Antithrombotic Therapy for Patients With Nonvalvular Atrial Fibrillation in Clinical Practice. J Am Heart Assoc. 2015 Jul 17; 4(7).
Score: 0.084
-
PREVENT and PCE Models for Estimating ASCVD Risk Stratified by Statin Exposure. JAMA Netw Open. 2025 Sep 02; 8(9):e2532164.
Score: 0.042
-
Association of Testosterone Replacement With Cardiovascular Outcomes Among Men With Androgen Deficiency. JAMA Intern Med. 2017 04 01; 177(4):491-499.
Score: 0.024
-
The impact of value-based benefit design on adherence to diabetes medications: a propensity score-weighted difference in difference evaluation. Value Health. 2010 Sep-Oct; 13(6):846-52.
Score: 0.015